Publication: Fibroblast growth factor-23 abolishes 1,25-dihydroxyvitamin D<inf>3</inf>-enhanced duodenal calcium transport in male mice
dc.contributor.author | Pissared Khuituan | en_US |
dc.contributor.author | Jarinthorn Teerapornpuntakit | en_US |
dc.contributor.author | Kannikar Wongdee | en_US |
dc.contributor.author | Panan Suntornsaratoon | en_US |
dc.contributor.author | Nipaporn Konthapakdee | en_US |
dc.contributor.author | Jintana Sangsaksri | en_US |
dc.contributor.author | Chanakarn Sripong | en_US |
dc.contributor.author | Nateetip Krishnamra | en_US |
dc.contributor.author | Narattaphol Charoenphandhu | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.contributor.other | Burapha University | en_US |
dc.date.accessioned | 2018-06-11T04:37:43Z | |
dc.date.available | 2018-06-11T04:37:43Z | |
dc.date.issued | 2012-04-15 | en_US |
dc.description.abstract | Despite being widely recognized as the important bone-derived phosphaturic hormone, whether fibroblast growth factor (FGF)-23 modulated intestinal calcium absorption remained elusive. Since FGF-23 could reduce the circulating level of 1,25-dihydroxyvitamin D 3 [1,25(OH) 2 D3], FGF-23 probably compromised the 1,25(OH) 2 D3 induced intestinal calcium absorption. FGF-23 may also exert an inhibitory action directly through FGF receptors (FGFR) in the intestinal cells. Herein, we demonstrated by Ussing chamber technique that male mice administered 1 μg/kg 1,25(OH) 2 D 3 sc daily for 3 days exhibited increased duodenal calcium absorption, which was abolished by concurrent intravenous injection of recombinant mouse FGF-23. This FGF-23 administration had no effect on the background epithelial electrical properties, i.e., short-circuit current, transepithelial potential difference, and resistance. Immunohistochemical evidence of protein expressions of FGFR isoforms 14 in mouse duodenal epithelial cells suggested a possible direct effect of FGF-23 on the intestine. This was supported by the findings that FGF-23 directly added to the serosal compartment of the Ussing chamber and completely abolished the 1,25(OH) 2 D3-induced calcium absorption in the duodenal tissues taken from the 1,25(OH) 2 D 3 -treated mice. However, direct FGF-23 exposure did not decrease the duodenal calcium absorption without 1,25(OH) 2 D 3 preinjection. The observed FGF-23 action was mediated by MAPK/ERK, p38 MAPK, and PKC. Quantitative real-time PCR further showed that FGF-23 diminished the 1,25(OH) 2 D3-induced upregulation of TRPV5, TRPV6, and calbindin-D 9k , but not PMCA 1b expression in the duodenal epithelial cells. In conclusion, besides being a phosphatonin, FGF-23 was shown to be a novel calcium-regulating hormone that acted directly on the mouse intestine, thereby compromising the 1,25(OH) 2 D 3 -induced calcium absorption. © 2012 the American Physiological Society. | en_US |
dc.identifier.citation | American Journal of Physiology - Endocrinology and Metabolism. Vol.302, No.8 (2012) | en_US |
dc.identifier.doi | 10.1152/ajpendo.00620.2011 | en_US |
dc.identifier.issn | 15221555 | en_US |
dc.identifier.issn | 01931849 | en_US |
dc.identifier.other | 2-s2.0-84859470865 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/13757 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84859470865&origin=inward | en_US |
dc.subject | Biochemistry, Genetics and Molecular Biology | en_US |
dc.subject | Medicine | en_US |
dc.title | Fibroblast growth factor-23 abolishes 1,25-dihydroxyvitamin D<inf>3</inf>-enhanced duodenal calcium transport in male mice | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84859470865&origin=inward | en_US |